157 related articles for article (PubMed ID: 12885844)
21. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
22. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
[TBL] [Abstract][Full Text] [Related]
23. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
25. PTEN expression and methylation status in oral squamous cell carcinoma.
Kurasawa Y; Shiiba M; Nakamura M; Fushimi K; Ishigami T; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Oncol Rep; 2008 Jun; 19(6):1429-34. PubMed ID: 18497947
[TBL] [Abstract][Full Text] [Related]
26. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
Engels K; Knauer SK; Metzler D; Simf C; Struschka O; Bier C; Mann W; Kovács AF; Stauber RH
J Pathol; 2007 Apr; 211(5):532-540. PubMed ID: 17334981
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.
Nomura H; Uzawa K; Ishigami T; Kouzu Y; Koike H; Ogawara K; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
BMC Cancer; 2008 Feb; 8():39. PubMed ID: 18237446
[TBL] [Abstract][Full Text] [Related]
29. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
[TBL] [Abstract][Full Text] [Related]
30. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
33. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
[TBL] [Abstract][Full Text] [Related]
34. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?
Lo Muzio L; Campisi G; Giovannelli L; Ammatuna P; Greco I; Staibano S; Pannone G; De Rosa G; Di Liberto C; D'Angelo M
Oral Oncol; 2004 Aug; 40(7):736-41. PubMed ID: 15172644
[TBL] [Abstract][Full Text] [Related]
35. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity.
Lo Muzio L; Farina A; Rubini C; Pezzetti F; Stabellini G; Laino G; Santarelli A; Pannone G; Bufo P; de Lillo A; Carinci F
Cancer Lett; 2005 Jul; 225(1):27-33. PubMed ID: 15922854
[TBL] [Abstract][Full Text] [Related]
36. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PAX5 in oral carcinogenesis.
Norhany S; Kouzu Y; Uzawa K; Hayama M; Higo M; Koike H; Kasamatu A; Tanzawa H
Oncol Rep; 2006 Nov; 16(5):1003-8. PubMed ID: 17016584
[TBL] [Abstract][Full Text] [Related]
38. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
39. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies.
Shiiba M; Saito K; Yamagami H; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2015 May; 46(5):1978-84. PubMed ID: 25738940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
